Atrium Therapeutics, Inc. (RNA)

$12.4 +6.16%
EARNINGS ANALYTICS
search

Atrium Therapeutics, Inc. (RNA) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -0.45% (May 14, 2026) and its biggest decline was -0.45% (May 14, 2026).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±0.45%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
May 14, 2026 ☽ POST $13.10 $13.45 $13.28 7,609 -0.45% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±0.45%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
SCHEDULE 13G 20260515 open_in_new SEC.gov
10-Q 20260514 open_in_new SEC.gov
8-K 20260514 open_in_new SEC.gov
SCHEDULE 13G 20260427 open_in_new SEC.gov
SCHEDULE 13G 20260427 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov
4 20260422 open_in_new SEC.gov

Frequently asked about RNA earnings

How much does RNA stock move after earnings? expand_more

Over 1 reports, RNA has moved an average of ±0.45% the session after earnings, closing higher 0.0% of the time.

What was RNA's biggest post-earnings move? expand_more

RNA's largest post-earnings gain on record was -0.45% on May 14, 2026, and its largest decline was -0.45% on May 14, 2026.

Where can I find Atrium Therapeutics, Inc.'s SEC filings? expand_more

All of Atrium Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers